J Cancer 2024; 15(5):1153-1168. doi:10.7150/jca.89660 This issue Cite

Research Paper

Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation

Alexandra Vernaza, Daniela F. Cardus, Jadyn L. Smith, Veronica Partridge, Amy L. Baker, Emma G. Lewis, Angela Zhang, Zhenze Zhao, Liqin Du

Department of Chemistry and Biochemistry, Texas State University, San Marcos, Texas.

Citation:
Vernaza A, Cardus DF, Smith JL, Partridge V, Baker AL, Lewis EG, Zhang A, Zhao Z, Du L. Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation. J Cancer 2024; 15(5):1153-1168. doi:10.7150/jca.89660. https://www.jcancer.org/v15p1153.htm
Other styles

File import instruction

Abstract

Graphic abstract

We conducted a high-content screening (HCS) in neuroblastoma BE(2)-C cells to identify cell cycle regulators that control cell differentiation using a library of siRNAs against cell cycle-regulatory genes. We discovered that knocking down expression of cyclin dependent kinase inhibitor 3 (CDKN3) showed the most potent effect in inducing neurite outgrowth, the morphological cell differentiation marker of neuroblastoma cells. We then demonstrated that CDKN3 knockdown increased expression of neuroblastoma molecular differentiation markers, neuron specific enolase (NSE), βIII-tubulin and growth associated protein 43 (GAP43). We further showed that CDKN3 knockdown reduced expression of cell proliferation markers Ki67 and proliferating cell nuclear antigen (PCNA), and reduced colony formation of neuroblastoma cells. More importantly, we observed a correlation of high tumor CDKN3 mRNA levels with poor patient survival in the investigation of public neuroblastoma patient datasets. In exploring the mechanisms that regulate CDKN3 expression, we found that multiple strong differentiation-inducing molecules, including miR-506-3p and retinoic acid, down-regulated CDKN3 expression. In addition, we found that N-Myc promoted CDKN3 expression at the transcriptional level by directly binding to the CDKN3 promoter. Furthermore, we found that CDKN3 and two additional differentiation-regulating cell cycle proteins identified in our HCS, CDC6 and CDK4, form an interactive network to promote expression of each other. In summary, we for the first time discovered the function of CDKN3 in regulating neuroblastoma cell differentiation and characterized the transcriptional regulation of CDKN3 expression by N-Myc in neuroblastoma cells. Our findings support that CDKN3 plays a role in modulating neuroblastoma cell differentiation and that overexpression of CDKN3 may contribute to neuroblastoma progression.

Keywords: cell cycle regulator, differentiation, differentiation therapy, neurite outgrowth, neuroblastoma


Citation styles

APA
Vernaza, A., Cardus, D.F., Smith, J.L., Partridge, V., Baker, A.L., Lewis, E.G., Zhang, A., Zhao, Z., Du, L. (2024). Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation. Journal of Cancer, 15(5), 1153-1168. https://doi.org/10.7150/jca.89660.

ACS
Vernaza, A.; Cardus, D.F.; Smith, J.L.; Partridge, V.; Baker, A.L.; Lewis, E.G.; Zhang, A.; Zhao, Z.; Du, L. Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation. J. Cancer 2024, 15 (5), 1153-1168. DOI: 10.7150/jca.89660.

NLM
Vernaza A, Cardus DF, Smith JL, Partridge V, Baker AL, Lewis EG, Zhang A, Zhao Z, Du L. Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation. J Cancer 2024; 15(5):1153-1168. doi:10.7150/jca.89660. https://www.jcancer.org/v15p1153.htm

CSE
Vernaza A, Cardus DF, Smith JL, Partridge V, Baker AL, Lewis EG, Zhang A, Zhao Z, Du L. 2024. Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation. J Cancer. 15(5):1153-1168.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image